Allspring Global Investments
AMPH icon

Allspring Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Allspring Global Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,326
Closed -$434K – 1626
2025
Q1 		$434K Buy
15,326
+1,262
+9% +$40.3K ﹤0.01% 1486
2024
Q4 		$511K Sell
14,064
-10,199
-42% -$466K ﹤0.01% 1455
2024
Q3 		$1.18M Sell
24,263
-16,683
-41% -$732K ﹤0.01% 1290
2024
Q2 		$1.64M Sell
40,946
-23,618
-37% -$979K ﹤0.01% 1221
2024
Q1 		$2.84M Buy
64,564
+24,678
+62% +$1.27M ﹤0.01% 1097
2023
Q4 		$2.47M Buy
39,886
+32,850
+467% +$1.73M ﹤0.01% 1123
2023
Q3 		$324K Buy
7,036
+1,082
+18% +$59K ﹤0.01% 1626
2023
Q2 		$342K Sell
5,954
-94,091
-94% -$4.17M ﹤0.01% 1651
2023
Q1 		$3.75M Sell
100,045
-10,320
-9% -$338K 0.01% 1067
2022
Q4 		$3.09M Sell
110,365
-116,159
-51% -$3.37M 0.01% 1120
2022
Q3 		$6.37M Buy
226,524
+167,471
+284% +$5.47M 0.01% 912
2022
Q2 		$2.05M Sell
59,053
-23,000
-28% -$821K ﹤0.01% 1217
2022
Q1 		$2.94M Sell
82,053
-169,908
-67% -$4.82M ﹤0.01% 1333
2021
Q4 		$5.87M Buy
+251,961
New +$5.15M 0.01% 1123

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allspring Global Investments's AMPH Position: Q2 2025 in Review

Allspring Global Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 15,326 shares — an estimated $434K sold.

Allspring Global Investments first reported a position in AMPH in Q4 2021 and held it in 14 quarters. The position peaked at $6.37M in Q3 2022. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • Allspring Global Investments reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 15,326 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $434K.
  • Allspring Global Investments first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's Amphastar Pharmaceuticals position peaked at $6.37M in Q3 2022.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.